MIRA INFORM REPORT

 

 

Report Date :

15.11.2013

 

IDENTIFICATION DETAILS

 

Name :

PENAM LABORATORIES LIMITED

 

 

Registered Office :

F – 223, New Rajinder Nagar, New Delhi -  110060

 

 

Country :

India

 

 

Financials (as on) :

31.03.2012

 

 

Date of Incorporation :

07.08.1989

 

 

Com. Reg. No.:

55-037287

 

 

Capital Investment / Paid-up Capital :

Rs.51.672 Millions

 

 

CIN No.:

[Company Identification No.]

U24231DL1989PLC037287

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

DELP08786B

 

 

PAN No.:

[Permanent Account No.]

AAACP0362M

 

 

Legal Form :

A Closely Held Public Limited Liability Company

 

 

Line of Business :

Manufacturer of Antibiotic Bulk Drugs, Cloxacillin Dicloxacillin Flucloxacillin Oxacillin Ampicillin Piperacillin Amoxicillin etc.

 

 

No. of Employees :

Information denied by management

 

RATING & COMMENTS

 

MIRA’s Rating :

B (32)

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Maximum Credit Limit :

USD 430000

 

 

Status :

Moderate

 

 

Payment Behaviour :

Slow but correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having moderate track record.

 

Profitability of the company appears to be low.

 

However, trade relations are fair. Business is active. Payment terms are slow but correct.

 

The company can be considered for business dealings with some caution.

 

NOTES:

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31st, 2013

 

Country Name

Previous Rating

(31.12.2012)

Current Rating

(31.03.2013)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

INDIAN ECONOMIC OVERVIEW

 

The current downturn provides an opportunity to push ahead with reforms to accelerate growth, says the latest India Development Update report released by the World Bank. The report says that the adverse effects of rupee depreciation are likely to be offset by the gains in the exports performance due to improved external competitiveness. Since May this year, the local currency has depreciated substantially and fell to a record level of Rs 68.85 to a dollar on August, 28.

 

A stagflation like situation appears to have arisen as inflation jumped to an eight month high of 6.46 % for the month of September. It is up from 6.10 % in August. Growth continues to be muted with factory output plunging to 0.6 % in August. Onion prices have risen nearly 300 % from last September. Vegetables cost nearly 90 % more than they did last year. Wake up to the economic contribution of slum dwellers. They contribute more than 7.5 % to the country’s gross domestic product, according to a recent study conducted in 50 top cities.

 

136000 estimated number of jobs created during the second quarter of the current financial year. 50000 estimated number of additional jobs in the field of corporate social responsibility in the coming years.

 

The International Finance Corporation expects to come out with its rupee linked bonds issue before the end of 2013 as a part of its plan to raise $ 1 billion. The Apple iPhone 5c (Rs 41900 for 16 GB variant) and 5s (Rs 53500 for 16GB variant) has been launched in India from 1st November.

 

The Land Acquisition Act to provide just and fair compensation to farmers will come into force from January 1 next year, said Rural Development Minister Jairam Ramesh. The Act replaces a 119 year old registration. The Securities and Exchange Board of India has approved the trading of currency futures on the Bombay Stock Exchange. The exchange plans to launch the currency futures platform with advanced trading technology by the end of November.

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

 

INFORMATION DENIED

 

Management Non Co-operative (Tel No. 91-11-32940065)

 

 

LOCATIONS

 

Registered Office :

F – 223, New Rajinder Nagar, New Delhi -  110060, India

Tel. No.:

91-11-32940065

Fax No.:

91-11-28741739

E-Mail :

penam@vsnl.net

Website :

www.penam.in

 

 

Manufacturing Facility and Research and Development Centre :

Joniawas Rewari, District Rewari - 123302, Haryana, India

Tel. No.:

91-1274-267286/267287

Fax No.:

91-1274-267285

E-Mail :

info@penam.in

 

 

DIRECTORS

 

As on 25.09.2012

 

Name :

Mr. Surinder Kumar Ajmani

Designation :

Director

Address :

F – 223, New Rajinder Nagar, New Delhi -  110060, India

Date of Birth/Age :

10.10.1939

Date of Appointment :

01.12.2013

DIN No.:

00466908

Other Directorship:

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U74899DL1971PTC005665

D KUMAR CONSULTING ENGINEERS PRIVATE LIMITED

Director

24/05/1973

24/05/1973

-

Active

NO

2

U74899DL1981PTC012273

CONTINENTAL MANUFACTURES PRIVATE LIMITED

Director

26/06/1983

26/06/1983

-

Active

NO

3

U24231DL1989PLC037287

PENAM LABORATORIES LIMITED

Managing director

01/12/2012

07/08/1989

-

Active

NO

 

 

Name :

Dr. Paras Nath Pandey

Designation :

Director

Address :

F – 223, New Rajinder Nagar, New Delhi -  110060, India

Date of Birth/Age :

02.02.1950

Date of Appointment :

07.08.1989

DIN No.:

00150374

 

 

Name :

Mr. Arun Kumar Mittal

Designation :

Director

Address :

F – 223, New Rajinder Nagar, New Delhi -  110060, India

Date of Birth/Age :

30.06.1954

Date of Appointment :

20.03.1993

DIN No.:

00049425

Other Directorship:

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

L51397DL1980PLC091361

CHEMCAPS LIMITED

Whole-time director

18/06/1983

18/06/1983

-

Active

NO

2

U24231DL1989PLC037287

PENAM LABORATORIES LIMITED

Director

20/03/1993

20/03/1993

-

Active

NO

3

L74999HR1988PLC030370

COVENTRY COIL-O-MATIC (HARYANA) LIMITED

Director

30/01/2001

30/01/2001

-

Active

NO

4

U74999DL2006PTC156177

PRODERNA BIOTECH PRIVATE LIMITED

Director

04/12/2006

04/12/2006

-

Active

NO

 

 

Name :

Mr. Ashish Ajmani

Designation :

Director

Address :

F – 223, New Rajinder Nagar, New Delhi -  110060, India

Date of Birth/Age :

15.03.1974

Date of Appointment :

01.12.2012

DIN No.:

00130788

Other Directorship:

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U74899DL1981PTC012273

CONTINENTAL MANUFACTURES PRIVATE LIMITED

Director

30/11/2000

30/11/2000

-

Active

NO

2

U24119DL2002PTC114197

SAMPARK OVERSEAS PRIVATE LIMITED

Director

13/02/2002

13/02/2002

-

Active

NO

3

U24231DL1989PLC037287

PENAM LABORATORIES LIMITED

Whole-time director

01/12/2012

05/10/2009

-

Active

NO

 

 

Name :

Mr. Madan Mohan Lal

Designation :

Director

Address :

F – 223, New Rajinder Nagar, New Delhi -  110060, India

Date of Birth/Age :

25.07.1942

Date of Appointment :

31.12.2009

DIN No.:

00130514

Other Directorship:

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U74899DL1993PTC055804

SAMPARK INTERNATIONAL PRIVATE LIMITED

Managing director

26/10/1993

26/10/1993

-

Active

NO

2

U24119DL2002PTC114197

SAMPARK OVERSEAS PRIVATE LIMITED

Director

13/02/2002

13/02/2002

-

Active

NO

3

U51909GJ2003PTC042323

AARA EXIM PRIVATE LIMITED

Director

01/04/2004

01/04/2004

07/07/2012

Active

NO

4

U24119DL2004PTC124681

SAMPARK FINE CHEM PRIVATE LIMITED.

Director

30/04/2004

30/04/2004

02/03/2007

Active

NO

5

U24231DL1989PLC037287

PENAM LABORATORIES LIMITED

Director

31/12/2009

05/10/2009

-

Active

NO

 

 

Name :

Mr. Narinder Mohan Jhanji

Designation :

Director

Address :

F – 223, New Rajinder Nagar, New Delhi -  110060, India

Date of Birth/Age :

16.01.1946

Date of Appointment :

05.10.2009

DIN No.:

02612674

 

 

MAJOR SHAREHOLDERS

 

As on 25.09.2012

 

SHAREHOLDIND DETAILS FILE ATTACHED

Equity Share Break up (Percentage of Total Equity)

 

As on 25.09.2012

 

Category

Percentage

Directors or relatives of Directors

80.00

Other top fifty shareholders

20.00

Total

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Antibiotic Bulk Drugs, Cloxacillin Dicloxacillin Flucloxacillin Oxacillin Ampicillin Piperacillin Amoxicillin etc.

 

 

Products :

Product Description

ITC Code

Cloxacilline

29411040

Dicloxacilline

29411090

Flucloxacilline

29411090

Others

29411090

 

PRODUCTION STATUS As on 31.03.2011

 

Particulars

Unit

Licensed Capacity

Installed Capacity

Actual Production

Goods

 

 

 

 

Bulk Drugs and Intermediates

MT

-

750.00 P.A.

391.696

Formulations

 

 

 

 

Capsules

Nos.

NA

150000000

2500000

Dry Surup

Bottles

NA

1500000

Nil

 

 

GENERAL INFORMATION

 

No. of Employees :

Information denied by management

 

 

Bankers :

  • State Bank of India, Industrial Finance Branch, Vijaya Building, New Delhi – 110001, India
  • State Bank of Patiala, World Trade Centre, New Delhi – 110001, India
  • IDBI Bank Limited, IDBI Tower, Cuffe Parade, Mumbai – 400005, Maharashtra, India

 

 

 

Banking Relations :

--

 

 

Financial Institutions :

  • Industrial Finance Corporation of India Limited, Nehru Place, New Delhi – 110019, India

 

 

Auditors :

 

Name :

Subodh Jain and Company

Chartered Accountants

Address :

Flat No 107 and 110 Sunder Kiran Plaza, 6/41 Western Extension Area, Ajmal Khan Road, Karol Bagh, New Delhi - 110005 India

PAN No.:

AAOFS1509C

 

 

Related Parties :

  • Raj Impex
  • Chemcaps Limited

CIN No.: L51397DL1980PLC091361

  • Sampark Overseas Private Limited

CIN No.: U24119DL2002PTC114197

  • Sampark International Private Limited

CIN No.: U74899DL1993PTC055804

 

 

 

CAPITAL STRUCTURE

 

As on 25.09.2012

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

10000000

Equity Shares

Rs. 10/- each

Rs.100.000 Millions

1000000

Preference Shares

Rs. 10/- each

Rs.10.000 Millions

 

Total

 

Rs.110.000 Millions

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

5167157

Equity Shares

Rs. 10/- each

Rs.51.672 Millions

 

 


FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

 

31.03.2012

(12 Months)

31.03.2011

(6 Months)

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

 

51.672

51.672

(b) Reserves & Surplus

 

54.841

51.134

(c) Money received against share warrants

 

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

 

0.000

0.000

Total Shareholders’ Funds (1) + (2)

 

106.513

102.806

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

 

0.000

0.000

(b) Deferred tax liabilities (Net)

 

3.696

4.117

(c) Other long term liabilities

 

17.300

17.300

(d) long-term provisions

 

2.611

2.341

Total Non-current Liabilities (3)

 

23.607

23.758

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

 

3.200

7.700

(b) Trade payables

 

258.737

287.311

(c) Other current liabilities

 

9.072

6.855

(d) Short-term provisions

 

3.085

5.747

Total Current Liabilities (4)

 

274.094

307.613

 

 

 

 

TOTAL

 

404.214

434.177

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

 

69.605

68.962

(ii) Intangible Assets

 

0.000

0.000

(iii) Capital work-in-progress

 

0.000

0.000

(iv) Intangible assets under development

 

0.000

0.000

(b) Non-current Investments

 

0.000

0.000

(c) Deferred tax assets (net)

 

0.000

0.000

(d)  Long-term Loan and Advances

 

0.000

0.000

(e) Other Non-current assets

 

0.000

0.000

Total Non-Current Assets

 

69.605

68.962

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

 

0.000

0.000

(b) Inventories

 

85.310

100.020

(c) Trade receivables

 

202.928

198.858

(d) Cash and cash equivalents

 

5.313

3.118

(e) Short-term loans and advances

 

11.393

11.251

(f) Other current assets

 

29.665

51.968

Total Current Assets

 

334.609

365.215

 

 

 

 

TOTAL

 

404.214

434.177

 

 

SOURCES OF FUNDS

 

 

 

30.09.2010

(12 Months)

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

 

 

51.672

2] Share Application Money

 

 

0.000

3] Reserves & Surplus

 

 

71.299

4] (Accumulated Losses)

 

 

0.000

NETWORTH

 

 

122.971

LOAN FUNDS

 

 

 

1] Secured Loans

 

 

0.129

2] Unsecured Loans

 

 

24.000

TOTAL BORROWING

 

 

24.129

DEFERRED TAX LIABILITIES

 

 

4.697

 

 

 

 

TOTAL

 

 

151.797

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

 

 

70.475

Capital work-in-progress

 

 

0.000

 

 

 

 

INVESTMENT

 

 

0.000

DEFERRED TAX ASSETS

 

 

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

 

 

78.390

 

Sundry Debtors

 

 

179.032

 

Cash & Bank Balances

 

 

3.079

 

Other Current Assets

 

 

0.000

 

Loans & Advances

 

 

50.762

Total Current Assets

 

 

311.263

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

 

 

200.295

 

Other Current Liabilities

 

 

10.924

 

Provisions

 

 

18.722

Total Current Liabilities

 

 

229.941

Net Current Assets

 

 

81.322

 

 

 

 

MISCELLANEOUS EXPENSES

 

 

0.000

 

 

 

 

TOTAL

 

 

151.797

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2012

(12 Months)

31.03.2011

(6 Months)

30.09.2010

(12 Months)

 

SALES

 

 

 

 

 

Income

839.273

531.289

970.897

 

 

Other Income

0.890

0.083

0.195

 

 

TOTAL                                         (A)

840.163

531.372

971.092

 

 

 

 

 

Less

EXPENSES

 

 

 

 

Cost of Materials Consumed

684.124

482.862

 

 

 

Changes in Inventories of finished goods, work-in-progress and stock-in-trade

16.928

(4.082)

 

 

 

Employee Benefits Expenses

30.390

14.163

 

 

 

Other Expenses

91.052

57.889

 

 

 

TOTAL                                         (B)

822.494

550.832

909.232

 

 

 

 

 

Less

PROFIT/(LOSS) BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)     (C)

17.669

(19.460)

61.860

 

 

 

 

 

Less

FINANCIAL EXPENSES                                    (D)

5.477

3.103

10.220

 

 

 

 

 

 

PROFIT/(LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                (E)

12.192

(22.563)

51.640

 

 

 

 

 

Less

DEPRECIATION/ AMORTISATION                     (F)

6.406

3.183

6.278

 

 

 

 

 

 

PROFIT/(LOSS) BEFORE TAX (E-F)                  (G)     

5.786

(25.746)

45.362

 

 

 

 

 

Less

TAX                                                                  (H)

2.079

(5.581)

15.327

 

 

 

 

 

 

PROFIT/(LOSS) AFTER TAX (G-H)                    (I)

3.707

(20.165)

30.035

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

FOB Value of Exports

355.327

180.156

259.269

 

TOTAL EARNINGS

355.327

180.156

259.269

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Value on CIF Basis

23.801

45.433

38.965

 

TOTAL IMPORTS

23.801

45.433

38.965

 

 

 

 

 

 

Earnings Per Share (Rs.)

0.72

(3.90)

5.09

 

 


KEY RATIOS

 

PARTICULARS

 

 

31.03.2012

31.03.2011

31.03.2010

PAT / Total Income

(%)

0.44

(3.79)

3.09

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

0.69

(4.84)

4.67

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

1.43

(5.93)

11.88

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.05

(0.25)

0.37

 

 

 

 

 

Debt Equity Ratio

(Total Debt /Networth)

 

0.03

0.07

0.20

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.22

1.19

1.35

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

No

9]

Name of person contacted

No

10]

Designation of contact person

No

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

-----------

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

----------

22]

Litigations that the firm / promoter involved in

----------

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

----------

26]

Buyer visit details

----------

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

UNSECURED LOANS:

 

Particulars

31.03.2012

Rs. In Millions

31.03.2011

Rs. In Millions

Long Term Borrowings

 

 

Intercorporate Deposite

0.000

5.000

Loans and advances from related parties

3.200

2.700

Total

3.200

7.700

 

OPERATIONS:

 

The Company has achieved sales turnover of Rs.839.273 Millions during the year (12 Months) as compared to Rs.531.289 Millions during the previous period (6 months). Company could have done better but due to limited availability of financial resources, only selective orders were executed.

 

FUTURE PROSPECTS:

 

The financial performance of the company is expected to improve linked to the limited financial resources.

 

INDEX OF CHARGE:

 

Sr. No.

Charge ID

Date of Charge Creation/Modification

Charge amount secured

Charge Holder

Address

Service Request Number (SRN)

1

10446773

04/09/2013

75,000,000.00

ORIENTAL BANK OF COMMERCE

A-BLOCK, CONNAUGHT PLACE, NEW DELHI, Delhi - 1100 01, INDIA

B83871095

FIXED ASSETS:

 

·         Plant and Machinery

·         Furniture and Fixture

·         Office Equipment’s

·         Computer Equipment

 

 

 

 

 

 

 

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.63.06

UK Pound

1

Rs.101.15

Euro

1

Rs.84.95

 

 

INFORMATION DETAILS

 

Information Gathered by :

NAY

 

 

Report Prepared by :

VNT

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

4

PAID-UP CAPITAL

1~10

3

OPERATING SCALE

1~10

4

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

4

--PROFITABILIRY

1~10

3

--LIQUIDITY

1~10

4

--LEVERAGE

1~10

4

--RESERVES

1~10

3

--CREDIT LINES

1~10

3

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

 

 

 

TOTAL

 

32

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NB

NEW BUSINESS

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.